Remimazolam-Fentanyl Mild Conscious Sedation Regimen in Pulsed-Field Ablation for Paroxysmal Atrial Fibrillation | MicrobiomeTrials← Back to trialsNCT07734194
Remimazolam-Fentanyl Mild Conscious Sedation Regimen in Pulsed-Field Ablation for Paroxysmal Atrial Fibrillation
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-01-01Est. Completion: 2026-08-01
Enrollment target: 20 participants Locations- University Hospital Kralovske Vinohrady, Prague, Czechia
Other microbiome trials you might be interested in
Atrial Fibrillation (AF)Persistant Atrial Fibrillation
The purpose of this study is to establish the safety of the pulsed field ablation (PFA) therapy of Pulmonary Veins and E…
Jonesboro, United StatesEst. completion Jul 2028
Paroxysmal AF
To obtain real world data on the use of, and provide continued evidence on safety and effectiveness of the FARAPULSE™ Pu…
Beijing, ChinaEst. completion Dec 31, 2027